共 32 条
[1]
Aulesa C, 2004, Lab Hematol, V10, P14, DOI 10.1532/LH96.03030
[2]
Aulesa C, 2003, Lab Hematol, V9, P15
[4]
Bourner G, 2005, Lab Hematol, V11, P285, DOI 10.1532/LH96.05036
[5]
Brown W., 2001, LAB HEMATOL, V7, P229
[6]
Chin-yee I., 2002, LAB HEMATOLOGY, V8, P210
[8]
Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin - The development of a prediction model
[J].
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS,
2008, 31 (04)
:369-374
[9]
ENGLAND JM, 1994, CLIN LAB HAEMATOL, V16, P157
[10]
Fernandez T., 2001, Laboratory Hematology, V7, P217